NETs released from LDGs displayed high levels of autoantigens and immune-stimulating molecules, including MMP-9, α- and β-defensins, and LL-37 [112], and the ability for SLE patients to clear NETs is impaired [173]. The gene discussed is CAMP; the disease is systemic lupus erythematosus.